Thomas Carlsson

2 months ago | autonomicneuroscience.com | Thomas Carlsson |Fernando Perez |Fernando Pérez |Michael Winder

Monotherapy continues to be the most common pharmacological treatment option for patients with overactive bladder (OAB), despite evidence indicating that it may have inferior efficacy compared to combination therapy. This seems to be especially true for patients with concomitant cystitis. The current study examined the effects of monotherapy with either the antimuscarinic tolterodine or the β3 agonist mirabegron on bladder overactivity induced by bladder inflammation.

Aug 5, 2024 | 4rfv.com | Thomas Carlsson

HMS Networks awarded Gold rating by EcoVadis 05 Aug 2024 at 22:00 By Thomas Carlsson Sustainability Reading time: 1 minutes HMS Networks has been awarded Gold rating by EcoVadis - the worlds most trusted provider of business sustainability ratings. EcoVadis assesses more than 90,000 companies across 160 countries to evaluate their sustainability work and help them improve environmental, social, and governance (ESG) practices.